Incidence of very high defibrillation thresholds (DFT) and efficacy of subcutaneous (SQ) array insertion during implantable cardioverter defibrillator (ICD) implantation

Journal of Interventional Cardiac Electrophysiology

Volumn 29, Issue 2, 2010, Pages 127-133

  Verma, Atul ^a   Kaplan, Alexander J ^a   Sarak, Bradley ^a   Oosthuizen, Richard ^a   Beardsall, Marianne ^a   Higgenbottam, Jan ^a   Wulffhart, Zaev ^a   Khaykin, Yaariv ^a  

^a SOUTHLAKE REGIONAL HEALTH CENTRE   (Canada)

Author keywords

Defibrillation thresholds; Implantable cardioverter defibrillator; Subcutaneous array

Indexed keywords

AMIODARONE;

ADULT; ARTICLE; CARDIOMYOPATHY; CONGESTIVE HEART FAILURE; DEFIBRILLATION THRESHOLD; DEFIBRILLATOR; DISEASE CLASSIFICATION; DRUG USE; ELECTRICAL POTENTIAL PARAMETERS; HEART ELECTROPHYSIOLOGY; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE SIZE; HEART RIGHT VENTRICLE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PATIENT SAFETY; PRIORITY JOURNAL; SHOCK WAVE; TREATMENT OUTCOME;

CANADA; DEFIBRILLATORS, IMPLANTABLE; ELECTRODES, IMPLANTED; EQUIPMENT FAILURE; FEMALE; HEART FAILURE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; TREATMENT OUTCOME;

EID: 78049415612     PISSN: 1383875X     EISSN: 15728595     Source Type: Journal    
DOI: 10.1007/s10840-010-9511-7     Document Type: Article

References (20)

1. LA Pires KM Johnson 2006 Intraoperative testing of the implantable cardioverter-defibrillator: how much is enough? Journal of Cardiovascular Electrophysiology 17 2 140 145 10.1111/j.1540-8167.2005.00294.x 16533250 (Pubitemid 43344864)
2. AM Russo W Sauer EP Gerstenfeld, et al. 2005 Defibrillation threshold testing: is it really necessary at the time of implantable cardioverter- defibrillator insertion? Heart Rhythm 2 5 456 461 10.1016/j.hrthm.2005.01.015 15840466 (Pubitemid 40521355)
3. MR Gold S Higgins R Klein, et al. 2002 Efficacy and temporal stability of reduced safety margins for ventricular defibrillation: primary results from the Low Energy Safety Study (LESS) Circulation 105 17 2043 2048 10.1161/01.CIR.0000015508.59749.F5 11980683 (Pubitemid 34465266)
4. V Kuhlkamp V Dornberger K Khalighi, et al. 1998 Effect of a single element subcutaneous array electrode added to a transvenous electrode configuration on the defibrillation field and the defibrillation threshold Pacing and Clinical Electrophysiology 21 12 2596 2605 1:STN:280: DyaK1M7ht1Shsw%3D%3D 10.1111/j.1540-8159.1998.tb00036.x 9894650 (Pubitemid 29031405)
5. JM Trusty DL Hayes MS Stanton, et al. 2000 Factors affecting the frequency of subcutaneous lead usage in implantable defibrillators Pacing and Clinical Electrophysiology 23 5 842 846 1:STN:280:DC%2BD3cvnsVaruw%3D%3D 10.1111/j.1540-8159.2000.tb00853.x 10833704
6. RE Ideker AE Epstein VJ Plumb 2005 Should shocks still be administered during implantable cardioverter-defibrillator insertion? Heart Rhythm 2 5 462 463 10.1016/j.hrthm.2005.02.004 15840467 (Pubitemid 40521356)
7. DA Theuns T Szili-Torok LJ Jordaens 2005 Defibrillation efficacy testing: long-term follow-up and mortality Europace 7 6 509 515 10.1016/j.eupc.2005.04. 005 16216750 (Pubitemid 41488092)
8. SK Mainigi DJ Callans 2006 How to manage the patient with a high defibrillation threshold Heart Rhythm 3 4 492 495 10.1016/j.hrthm.2005.12.023 16567304
9. JD Day B Olshansky S Moore, et al. 2008 High defibrillation energy requirements are encountered rarely with modern dual-chamber implantable cardioverter-defibrillator systems Europace 10 3 347 350 10.1093/europace/eun027 18308755 (Pubitemid 351773742)
10. DM Hodgson MR Olsovsky SR Shorofsky, et al. 2002 Clinical predictors of defibrillation thresholds with an active pectoral pulse generator lead system Pacing and Clinical Electrophysiology 25 4 Pt 1 408 413 10.1046/j.1460-9592. 2002.00408.x 11991364
11. A Lubinski E Lewicka-Nowak A Zienciuk, et al. 2005 Clinical predictors of defibrillation threshold in patients with implantable cardioverter- defibrillators Kardiologia Polska 62 4 317 328 15928737 discussion 329-331
12. HH Shukla GC Flaker V Jayam, et al. 2003 High defibrillation thresholds in transvenous biphasic implantable defibrillators: clinical predictors and prognostic implications Pacing and Clinical Electrophysiology 26 1 Pt 1 44 48 10.1046/j.1460-9592.2003.00148.x 12685138
13. D Birnie S Tung C Simpson, et al. 2008 Complications associated with defibrillation threshold testing: the Canadian experience Heart Rhythm 5 3 387 390 10.1016/j.hrthm.2007.11.018 18243813
14. SH Hohnloser P Dorian R Roberts, et al. 2006 Effect of amiodarone and sotalol on ventricular defibrillation threshold: the optimal pharmacological therapy in cardioverter defibrillator patients (OPTIC) trial Circulation 114 2 104 109 1:CAS:528:DC%2BD28XmsVGjsLY%3D 10.1161/CIRCULATIONAHA.106.618421 16818810 (Pubitemid 44420741)
15. A Bollmann D Husser DS Cannom 2005 Antiarrhythmic drugs in patients with implantable cardioverter-defibrillators American Journal of Cardiovascular Drugs 5 6 371 378 1:CAS:528:DC%2BD2MXhtlWhu7%2FM 10.2165/00129784-200505060-00004 16259525 (Pubitemid 41594552)
16. C Schuger KA Ellenbogen M Faddis, et al. 2006 Defibrillation energy requirements in an ICD population receiving cardiac resynchronization therapy Journal of Cardiovascular Electrophysiology 17 3 247 250 10.1111/j.1540-8167. 2006.00345.x 16643394 (Pubitemid 43344931)
17. K Kettering C Mewis V Dornberger, et al. 2004 Long-term experience with subcutaneous ICD leads: a comparison among three different types of subcutaneous leads Pacing and Clinical Electrophysiology 27 10 1355 1361 10.1111/j.1540-8159.2004.00639.x 15511244 (Pubitemid 39463653)
18. A Zienciuk A Lubinski T Krolak, et al. 2007 Effects of shock polarity reversal on defibrillation threshold in an implantable cardioverter- defibrillator Kardiologia Polska 65 5 495 500 17577846 discussion 501-492
19. D Keane N Aweh B Hynes, et al. 2007 Achieving sufficient safety margins with fixed duration waveforms and the use of multiple time constants Pacing and Clinical Electrophysiology 30 5 596 602 10.1111/j.1540-8159.2007.00718.x 17461867 (Pubitemid 46653148)
20. JA Blatt JE Poole GW Johnson, et al. 2008 No benefit from defibrillation threshold testing in the SCD-HeFT (Sudden Cardiac Death in Heart Failure Trial) Journal of the American College of Cardiology 52 7 551 556 10.1016/j.jacc.2008. 04.051 18687249